Antidepressants in social anxiety disorder

Arquivos de Neuro-Psiquiatria

Antonio E. Nardi¹ 

[1] ,Federal University of Rio de Janeiro Institute of PsychiatryRJ ,Brazil

关键词: social anxiety disorder;    social phobia;    pharmacologic treatment;    fobia social;    transtorno de ansiedade social;    tratamento farmacológico;   

DOI  :  10.1590/S0004-282X2001000400032

来源: SciELO

【 摘 要 】

Social anxiety disorder (SAD) is a marked and persistent fear of doing almost everything in front of people due to concerns about being judge by others. An up-to-date review is needed in order to reach a practical judgement of all psychopharmacological data. Case reports, open and double-blind trials with SAD were described and commented upon from a clinical point of view. The MEDLINE system was searched from 1975 to 2001. The references from the selected papers were also used as a source. MAOIs (fenelzine, tranylcypromine), reversible monoamino oxidase-A inhibitors (moclobemide, brofaromine), SSRIs (paroxetine, sertraline, fluoxetine, fluvoxamine) and some other antidepressants (venlafaxine, nefazodone) have proven effective in several studies with various methodologies. The MAOIs have more serious adverse effects and the SSRIs have the best tolerance. SSRIs are efficacious and the first choice of treatment.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License